Docebo Inc. (DCBO) stock
DCBONasdaqServices-Prepackaged SoftwareFiscal year ends December 31
$32.46−0.02 (-0.06%)
Close on Nov 13, 2026Market cap $933.14MP/E 25.4Yield –
Docebo r&d expenses
Research and development expenses are spending on new products and technology.
Docebo's R&D Expenses for the twelve months ending Jun 30, 2025 was $48.83M. For fiscal 2025 it was $50.12M, up 14.1% from the year before. The highest annual figure on record is $50.12M in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $50.12M | +14.1% |
| FY2024 | Dec 31, 2024 | $43.91M | +23.8% |
| FY2023 | Dec 31, 2023 | $35.48M | +43.2% |
| FY2022 | Dec 31, 2022 | $24.78M | +21.7% |
| FY2021 | Dec 31, 2021 | $20.36M | +52.1% |
| FY2020 | Dec 31, 2020 | $13.38M | +41.8% |
| FY2019 | Dec 31, 2019 | $9.44M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $12.99M | +12.2% |
| Q1 FY2026 | Mar 31, 2026 | $15.46M | +38.6% |
| Q2 FY2025 | Jun 30, 2025 | $12.70M | +22.0% |
| Q1 FY2025 | Mar 31, 2025 | $13.40M | +48.5% |
| Q4 FY2024 | Dec 31, 2024 | $11.58M | +12.7% |
| Q3 FY2024 | Sep 30, 2024 | $11.15M | +26.6% |
| Q1 FY2024 | Mar 31, 2024 | $10.41M | +41.1% |
| Q4 FY2023 | Dec 31, 2023 | $9.02M | +41.5% |
| Q3 FY2023 | Sep 30, 2023 | $10.27M | +68.2% |
| Q2 FY2023 | Jun 30, 2023 | $8.81M | +44.2% |
| Q1 FY2023 | Mar 31, 2023 | $7.38M | +19.3% |
| Q4 FY2022 | Dec 31, 2022 | $6.38M | +15.8% |
| Q3 FY2022 | Sep 30, 2022 | $6.11M | +11.4% |
| Q2 FY2022 | Jun 30, 2022 | $6.11M | +16.7% |
| Q1 FY2022 | Mar 31, 2022 | $6.19M | +49.3% |
| Q4 FY2021 | Dec 31, 2021 | $5.51M | – |
| Q3 FY2021 | Sep 30, 2021 | $5.48M | – |
| Q2 FY2021 | Jun 30, 2021 | $5.23M | – |
| Q1 FY2021 | Mar 31, 2021 | $4.14M | – |
See a number that looks wrong?